<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:51:44Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6667894" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6667894</identifier>
        <datestamp>2019-08-06</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="brief-report">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Diabetes Obes Metab</journal-id>
              <journal-id journal-id-type="iso-abbrev">Diabetes Obes Metab</journal-id>
              <journal-id journal-id-type="doi">10.1111/(ISSN)1463-1326</journal-id>
              <journal-id journal-id-type="publisher-id">DOM</journal-id>
              <journal-title-group>
                <journal-title>Diabetes, Obesity &amp; Metabolism</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1462-8902</issn>
              <issn pub-type="epub">1463-1326</issn>
              <publisher>
                <publisher-name>Blackwell Publishing Ltd</publisher-name>
                <publisher-loc>Oxford, UK</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6667894</article-id>
              <article-id pub-id-type="pmcid">PMC6667894</article-id>
              <article-id pub-id-type="pmc-uid">6667894</article-id>
              <article-id pub-id-type="pmid">30098126</article-id>
              <article-id pub-id-type="doi">10.1111/dom.13500</article-id>
              <article-id pub-id-type="publisher-id">DOM13500</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Brief Report</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Brief Reports</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease</article-title>
                <alt-title alt-title-type="left-running-head">Chambers et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="dom13500-cr-0001" contrib-type="author">
                  <name>
                    <surname>Chambers</surname>
                    <given-names>Edward S.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7074-1312</contrib-id>
                  <xref ref-type="aff" rid="dom13500-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0002" contrib-type="author">
                  <name>
                    <surname>Byrne</surname>
                    <given-names>Claire S.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0003" contrib-type="author">
                  <name>
                    <surname>Rugyendo</surname>
                    <given-names>Annette</given-names>
                  </name>
                  <degrees>RD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0004" contrib-type="author">
                  <name>
                    <surname>Morrison</surname>
                    <given-names>Douglas J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0005" contrib-type="author">
                  <name>
                    <surname>Preston</surname>
                    <given-names>Tom</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0006" contrib-type="author">
                  <name>
                    <surname>Tedford</surname>
                    <given-names>Catriona</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0007" contrib-type="author">
                  <name>
                    <surname>Bell</surname>
                    <given-names>Jimmy D.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0008" contrib-type="author">
                  <name>
                    <surname>Thomas</surname>
                    <given-names>Louise</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0009" contrib-type="author">
                  <name>
                    <surname>Akbar</surname>
                    <given-names>Arne N.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0010" contrib-type="author">
                  <name>
                    <surname>Riddell</surname>
                    <given-names>Natalie E.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0011" contrib-type="author">
                  <name>
                    <surname>Sharma</surname>
                    <given-names>Rohini</given-names>
                  </name>
                  <degrees>MBBS</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0012" contrib-type="author">
                  <name>
                    <surname>Thursz</surname>
                    <given-names>Mark R.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0013" contrib-type="author">
                  <name>
                    <surname>Manousou</surname>
                    <given-names>Pinelopi</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="dom13500-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="dom13500-cr-0014" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Frost</surname>
                    <given-names>Gary</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <address>
                    <email>g.frost@imperial.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="dom13500-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="dom13500-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Section for Nutrition Research, Faculty of Medicine</named-content>
                <institution>Imperial College London, Hammersmith Hospital</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Stable Isotope Biochemistry Laboratory</named-content>
                <institution>Scottish Universities Environmental Research Centre, University of Glasgow</institution>
                <named-content content-type="city">Glasgow</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">School of Science</named-content>
                <institution>University of the West of Scotland</institution>
                <named-content content-type="city">Hamilton</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Life Sciences, Faculty of Science and Technology, Research Centre for Optimal Health</named-content>
                <institution>University of Westminster</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Division of Infection and Immunity</named-content>
                <institution>University College London</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Faculty of Health and Medical Sciences</named-content>
                <institution>University of Surrey</institution>
                <named-content content-type="city">Guildford</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Department of Surgery and Cancer</named-content>
                <institution>Imperial College London</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">UK</country>
              </aff>
              <aff id="dom13500-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">Liver Unit</named-content>
                <institution>St Mary's Hospital, Imperial College NHS Trust</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">UK</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Gary Frost PhD, Section for Nutrition Research, Faculty of Medicine, Imperial College London, 6th Floor Commonwealth Building, Hammersmith Hospital, London W12 0NN, UK.<break/>
Email: <email>g.frost@imperial.ac.uk</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>16</day>
                <month>9</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>2</month>
                <year>2019</year>
              </pub-date>
              <volume>21</volume>
              <issue>2</issue>
              <issue-id pub-id-type="doi">10.1111/dom.2019.21.issue-2</issue-id>
              <fpage>372</fpage>
              <lpage>376</lpage>
              <history>
                <date date-type="received">
                  <day>16</day>
                  <month>5</month>
                  <year>2018</year>
                </date>
                <date date-type="rev-recd">
                  <day>30</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>8</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 John Wiley & Sons Ltd <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Diabetes, Obesity and Metabolism</italic> Published by John Wiley &amp; Sons Ltd</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:DOM-21-372.pdf"/>
              <abstract>
                <p>The short chain fatty acid (SCFA) propionate, produced through fermentation of dietary fibre by the gut microbiota, has been shown to alter hepatic metabolic processes that reduce lipid storage. We aimed to investigate the impact of raising colonic propionate production on hepatic steatosis in adults with non‐alcoholic fatty liver disease (NAFLD). Eighteen adults were randomized to receive 20 g/d of an inulin‐propionate ester (IPE), designed to deliver propionate to the colon, or an inulin control for 42 days in a parallel design. The change in intrahepatocellular lipid (IHCL) following the supplementation period was not different between the groups (<italic>P</italic> = 0.082), however, IHCL significantly increased within the inulin‐control group (20.9% ± 2.9% to 26.8% ± 3.9%; <italic>P</italic> = 0.012; <italic>n</italic> = 9), which was not observed within the IPE group (22.6% ± 6.9% to 23.5% ± 6.8%; <italic>P</italic> = 0.635; <italic>n</italic> = 9). The predominant SCFA from colonic fermentation of inulin is acetate, which, in a background of NAFLD and a hepatic metabolic profile that promotes fat accretion, may provide surplus lipogenic substrate to the liver. The increased colonic delivery of propionate from IPE appears to attenuate this acetate‐mediated increase in IHCL.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="dom13500-kwd-0001">clinical trial</kwd>
                <kwd id="dom13500-kwd-0002">dietary intervention</kwd>
                <kwd id="dom13500-kwd-0003">fatty liver</kwd>
                <kwd id="dom13500-kwd-0004">insulin resistance</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>NIHR Clinical Research Facility at Imperial College Healthcare NHS Trust</funding-source>
                </award-group>
                <award-group>
                  <funding-source>MRC Confidence in Concept fund</funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="1"/>
                <page-count count="5"/>
                <word-count count="4059"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>dom13500</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>February 2019</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.6.2 mode:remove_FC converted:31.07.2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="dom13500-cit-9001"><string-name><surname>Chambers</surname><given-names>ES</given-names></string-name>, <string-name><surname>Byrne</surname><given-names>CS</given-names></string-name>, <string-name><surname>Rugyendo</surname><given-names>A</given-names></string-name>, et al. <article-title>The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease</article-title>. <source xml:lang="en">Diabetes Obes Metab</source>. <year>2019</year>;<volume>21</volume>:<fpage>372</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1111/dom.13500</pub-id>
<pub-id pub-id-type="pmid">30098126</pub-id></mixed-citation>
              </p>
              <fn-group>
                <fn id="dom13500-note-0101">
                  <p><bold>Funding information</bold> This research study was supported by the NIHR Clinical Research Facility at Imperial College Healthcare NHS Trust. The research was supported by an MRC Confidence in Concept fund.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <sec id="dom13500-sec-0001">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Non‐alcoholic fatty liver disease (NAFLD), a condition characterized by the accumulation of fat within the liver, is regarded as a major risk factor in the development of type 2 diabetes.<xref rid="dom13500-bib-0001" ref-type="ref">1</xref> The prevalence of NAFLD is strongly associated with obesity,<xref rid="dom13500-bib-0001" ref-type="ref">1</xref> thus current guidelines for the prevention and management of NAFLD are based solely on body weight loss through diet and exercise.<xref rid="dom13500-bib-0001" ref-type="ref">1</xref> While lifestyle modifications are successful in reducing body weight in the short term, numerous studies show that long‐term maintenance of body weight loss in obese individuals is very poor.<xref rid="dom13500-bib-0002" ref-type="ref">2</xref> Lifestyle modifications alone are therefore unlikely to reduce the growing prevalence of NAFLD and there is an urgent need to develop therapeutic interventions that can safely be applied at the population level.</p>
              <p>Recent investigations suggest that diet, the gut microbiota and liver fat storage could be linked through a mechanism involving short chain fatty acids (SCFA), the major products of dietary fibre fermentation in the colon. It has been repeatedly observed that when animals are fed fermentable fibre they are protected against steatosis induced by high fat diets.<xref rid="dom13500-bib-0003" ref-type="ref">3</xref>, <xref rid="dom13500-bib-0004" ref-type="ref">4</xref>, <xref rid="dom13500-bib-0005" ref-type="ref">5</xref> This effect may be because of the SCFA propionate, as ~90% of propionate produced in the colon is extracted from the portal vein by the liver,<xref rid="dom13500-bib-0006" ref-type="ref">6</xref> which has been shown to alter hepatic metabolic processes to reduce lipid content.<xref rid="dom13500-bib-0007" ref-type="ref">7</xref>, <xref rid="dom13500-bib-0008" ref-type="ref">8</xref> To augment colonic propionate production we have developed an inulin‐propionate ester (IPE), whereby the SCFA propionate is bound to the dietary fibre inulin, which is released through microbial hydrolysis in the colon.<xref rid="dom13500-bib-0009" ref-type="ref">9</xref> Our recent first‐in‐human studies provided preliminary evidence that supplementing the diet with 10 g/d IPE for 24 weeks reduced liver fat content in adults with NAFLD.<xref rid="dom13500-bib-0009" ref-type="ref">9</xref> These volunteers were identified as having NAFLD on the basis of an elevated intrahepatocellular lipid (IHCL) content from magnetic resonance imaging.</p>
              <p>The aim of the current study was to develop in vivo proof‐of‐concept for IPE as a therapeutic to reduce hepatic steatosis in volunteers with a histological confirmation of NAFLD, which is considered the gold standard to establish diagnosis. We hypothesized that the addition of 20 g IPE to the diet of adults with NAFLD for 42 days would significantly reduce IHCL compared with 20 g of an inulin control.</p>
            </sec>
            <sec id="dom13500-sec-0002">
              <label>2</label>
              <title>METHODS</title>
              <p>All volunteers provided informed, written consent prior to the clinical trial which was approved by the London Brent Research Ethics Committee (14/LO/0645). The study was carried out in accordance with the Declaration of Helsinki and is registered with the ISRCTN registry (ISRCTN71814178). A detailed methodology is presented in File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref> for this article. Men and women aged 18 to 65 years, with a body mass index (BMI) of 20 to 40 kg/m<sup>2</sup> were recruited from liver clinics at St Mary's Hospital, Imperial College Healthcare National Health Service Trust. Potential volunteers were eligible if they had a confirmation of NAFLD by liver biopsy within the previous 5 years and controlled blood glucose levels (HbA1c &lt; 48 mmol/mol). The study was conducted using a randomized, double‐blind, placebo‐controlled, parallel design. Subjects received either 20 g/d of inulin control or IPE for 42 days. The 20 g dose of IPE would have provided 14.6 g of inulin (and 5.4 g bound propionate) to the diet.<xref rid="dom13500-bib-0009" ref-type="ref">9</xref> Inulin was therefore chosen as a positive control to account for any effects that may derive from fermentation of this substrate by the gut microbiota. The supplements were provided to volunteers in 10 g ready‐to‐use sachets and they were instructed to mix the contents into their habitual diet twice a day. Participants were required to attend the NIHR Imperial Clinical Research Facility pre‐ (day 0) and postsupplementation (day 42) to determine outcome measures.</p>
            </sec>
            <sec id="dom13500-sec-0003">
              <label>3</label>
              <title>RESULTS AND DISCUSSION</title>
              <p>Of 20 volunteers that were randomized and enrolled into the study, data were analysed from the 18 volunteers that completed the supplementation period (Figure <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>). The characteristics of these volunteers are presented in Tables <xref rid="dom13500-tbl-0001" ref-type="table">1</xref> and <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref> (File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>). Estimated compliance was similar in the supplementation groups (inulin control: 90% ± 7% vs. IPE: 95% ± 2%; <italic>P</italic> = 0.213). The changes in IHCL (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>A‐C and Table <xref rid="dom13500-tbl-0001" ref-type="table">1</xref>) were unexpected, as we observed an increase in IHCL postsupplementation in both groups (main effect for time; <italic>P</italic> = 0.020). The change in IHCL was not significantly different between supplementation groups (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>A; <italic>P</italic> = 0.082), however, within‐group analysis showed that IHCL was significantly increased within the inulin‐control group (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>B; <italic>P</italic> = 0.012) and not the IPE group (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>C; <italic>P</italic> = 0.635). Analysis of metabolic and inflammatory responses (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>D‐I, Figure <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S2</xref>; Tables <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S2‐S4</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>) highlights that the change in insulin resistance (HOMA‐IR) was significantly different between groups (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>D; <italic>P</italic> = 0.046), with a non‐significant increase in the inulin‐control group (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>E; <italic>P</italic> = 0.060) and decrease in the IPE group (Figure <xref rid="dom13500-fig-0001" ref-type="fig">1</xref>E; <italic>P</italic> = 0.389), respectively. There were no within‐ or between‐group differences in body composition (Table <xref rid="dom13500-tbl-0001" ref-type="table">1</xref>), self‐reported food intake or physical activity following the supplementation period (Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S5</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>). Our hypothesis was that IPE supplementation would decrease IHCL in adults with NAFLD, as observed in our previous study<xref rid="dom13500-bib-0009" ref-type="ref">9</xref>; however, IPE supplementation did not reduce liver fat content. The disparate outcome may be explained by methodological differences in IPE dose (10 g/d vs. 20 g/d) and exposure (6 weeks vs. 24 weeks) in the two studies. Furthermore, volunteers in the current study had a confirmation of NAFLD by liver biopsy, which is considered the gold standard to establish diagnosis, and metabolic parameters would indicate these individuals had poorer glycaemic control compared with the volunteers from our previous study (fasting glucose: 5.0 mmol/L vs. 6.1 mmol/L; HbA1c: 38 mmol/mol vs. 42 mmol/mol).</p>
              <table-wrap id="dom13500-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                <label>Table 1</label>
                <caption>
                  <p>Baseline characteristics of volunteers and changes in intrahepatocellular lipid and body composition following 42 days of inulin control or inulin‐propionate ester (IPE) supplementation</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                      <th colspan="3" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Inulin control</th>
                      <th colspan="3" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">IPE</th>
                      <th colspan="2" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Mixed ANOVA</th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                      <th colspan="3" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">(n = 9)</th>
                      <th colspan="3" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">(n = 9)</th>
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Time</th>
                      <th style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Group × Time</th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Pre</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Post</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Pre</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Post</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> value</th>
                      <th style="border-right:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> value</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Sex (n)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Male</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Female</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Race or ethnicity (n)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">White</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Asian</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Age (years)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">49 ± 4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">51 ± 4</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Diabetes (Y/N)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">3/6</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">2/7</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Dyslipidaemia (Y/N)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5/4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">5/4</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Hypertension (Y/N)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2/7</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">2/7</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Liver biopsy histology (NAFLD/NASH)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">6/3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">7/2</td>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td style="border-right:solid 1px #000000; padding-left:10%" align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>IHCL (%)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20.9 ± 2.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">26.8 ± 3.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.012</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">22.6 ± 6.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">23.5 ± 6.8</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.635</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.020</td>
                      <td style="border-right:solid 1px #000000" align="left" valign="top" rowspan="1" colspan="1">0.082</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Body weight (kg)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">83.3 ± 4.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">83.2 ± 4.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.914</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">93.6 ± 7.6</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">93.9 ± 7.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.556</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.438</td>
                      <td style="border-right:solid 1px #000000" align="left" valign="top" rowspan="1" colspan="1">0.578</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>BMI (kg/m</bold>
                        <sup>
                          <bold>2</bold>
                        </sup>
                        <bold>)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">29.5 ± 1.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">29.5 ± 1.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.966</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">31.5 ± 1.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">31.6 ± 1.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.377</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.696</td>
                      <td style="border-right:solid 1px #000000" align="left" valign="top" rowspan="1" colspan="1">0.620</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Fat mass (kg)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">26.8 ± 3.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">27.1 ± 3.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.524</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">35.3 ± 5.2</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">34.9 ± 5.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.485</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.931</td>
                      <td style="border-right:solid 1px #000000" align="left" valign="top" rowspan="1" colspan="1">0.302</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">
                        <bold>Fat free mass (kg)</bold>
                      </td>
                      <td align="left" valign="top" rowspan="1" colspan="1">56.5 ± 3.7</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">56.1 ± 3.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.631</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">58.3 ± 5.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">59.1 ± 5.2</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.055+</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.748</td>
                      <td style="border-right:solid 1px #000000" align="left" valign="top" rowspan="1" colspan="1">0.341</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="dom13500-note-0002">
                    <p>Abbreviations: BMI, body mass index; IHCL, intrahepatocellular lipid; NAFLD, non‐alcoholic fatty liver disease; NASH, non‐alcoholic steatohepatitis.</p>
                  </fn>
                  <fn id="dom13500-note-0003">
                    <p>+ = non‐parametric statistical analysis.</p>
                  </fn>
                  <fn id="dom13500-note-0004">
                    <p>Detailed volunteer characteristics are presented in Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>.</p>
                  </fn>
                  <fn id="dom13500-note-0005">
                    <p>Data are expressed as mean ± SEM.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <fig fig-type="Figure" xml:lang="en" id="dom13500-fig-0001" orientation="portrait" position="float">
                <label>Figure 1</label>
                <caption>
                  <p>Effects of 42 days of inulin control and inulin‐propionate ester (IPE) supplementation on liver fat and glucose homeostasis. A to C, Intrahepatocellular lipid (IHCL); D to F, homeostatic model assessment of insulin resistance (HOMA‐IR); and G to I, glycosylated haemoglobin (HbA1c). Group data (A, D and G) are expressed as mean ± SEM (n = 9)</p>
                </caption>
                <graphic id="nlm-graphic-1" xlink:href="DOM-21-372-g001"/>
              </fig>
              <p>Whilst breath hydrogen, a marker of colonic fermentation, was elevated in both groups postsupplementation (Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S3</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>), the impact on SCFAs measured in peripheral blood was limited, as we observed that IPE supplementation only reduced levels of butyrate in fasting samples compared to the inulin‐control group (Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S3</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>). The blood samples were collected &gt;12 hours after volunteers were requested to ingest their final supplement, which may explain why we were unable to detect large differences in circulating SCFAs postsupplementation. Nevertheless, previous research using stable isotope methodology has showed that inulin is predominantly fermented in the human colon into acetate (82%), with considerably less propionate and butyrate produced (6% and 12%, respectively).<xref rid="dom13500-bib-0010" ref-type="ref">10</xref> Dietary supplementation with inulin‐type fructans (ITF) has generally been associated with positive effects on metabolic health. The evidence for this beneficial effect is primarily derived from rodent studies, where dietary supplementation with ITF has consistently been shown to prevent the accumulation of liver fat and metabolic dysregulation induced by a high fat diet.<xref rid="dom13500-bib-0003" ref-type="ref">3</xref>, <xref rid="dom13500-bib-0004" ref-type="ref">4</xref>, <xref rid="dom13500-bib-0005" ref-type="ref">5</xref> However, to the best of our knowledge, ITF have not been shown to reduce liver fat when added to the diets of rodents with pre‐existing steatosis. Studies investigating the effect of ITF on metabolic health in humans are equivocal, with a recent meta‐analysis reporting no association between ITF supplementation and fasting glucose and insulin levels.<xref rid="dom13500-bib-0011" ref-type="ref">11</xref> Fewer studies have quantified the impact of ITF supplementation on liver fat content in humans. Our previous work showed that 30 g/d ITF supplemented into the habitual diet of overweight adults with normal glycaemic control had no effect on IHCL.<xref rid="dom13500-bib-0012" ref-type="ref">12</xref> In contrast, a superior reduction in IHCL in adults with prediabetes was found when a weight‐loss diet was combined with 30 g/d ITF supplementation.<xref rid="dom13500-bib-0013" ref-type="ref">13</xref> The serendipitous observation in the current study is that supplementing 20 g/d inulin into a habitual weight‐maintaining diet raises IHCL and further exacerbates glucose homeostasis in adults with NAFLD. Taken together, our data suggest that ITF supplementation does not have a homogenous impact on hepatic lipid content in humans, and its effects may depend on the pre‐existing metabolic health of the individual and the energy‐balance promoted by the background diet.</p>
              <p>Previous research would suggest that the acetate derived from inulin fermentation would have contrasting metabolic fates depending on hepatic lipid metabolism in different physiological conditions. For example, it has previously been reported that greater amounts of exogenous acetate are used for hepatic de novo lipogenesis (DNL) in obese compared to lean individuals. This metabolic response was associated with higher insulin levels in the obese group, which is the chief regulator of hepatic DNL.<xref rid="dom13500-bib-0014" ref-type="ref">14</xref> Previous work has also showed that chronic intragastric acetate infusion in rats promotes postprandial hyperinsulinaemia and increases liver triglyceride content.<xref rid="dom13500-bib-0015" ref-type="ref">15</xref> The conversion of SCFAs into metabolic intermediates is initially determined by the acyl‐CoA synthetase short‐chain family members (ACSS).<xref rid="dom13500-bib-0016" ref-type="ref">16</xref> Human hepatocytes express the cytosolic isoform <italic>ACSS2</italic>, which has high specificity for acetate and increases the availability of acetyl‐CoA for lipid synthesis.<xref rid="dom13500-bib-0016" ref-type="ref">16</xref> Evidence highlights that, together with higher insulin levels,<xref rid="dom13500-bib-0017" ref-type="ref">17</xref> humans with NAFLD have an elevated expression of hepatic genes that favour fat accumulation, with increased expression of acetyl‐CoA carboxylase (ACC) and fatty acid synthase (FASN), which are key enzymes in hepatic DNL.<xref rid="dom13500-bib-0018" ref-type="ref">18</xref> Consequently, NAFLD patients are reported to have rates of DNL up to 3‐fold higher compared with BMI‐matched controls.<xref rid="dom13500-bib-0017" ref-type="ref">17</xref> The current data suggest that in body weight‐stable individuals with NAFLD, an increased supply of acetate to the liver from the colonic fermentation of inulin provides surplus acetyl‐CoA for DNL and hepatic lipid accretion. Interestingly, diet‐induced body weight loss in mice has been shown to markedly reduce insulin levels and rates of hepatic DNL,<xref rid="dom13500-bib-0019" ref-type="ref">19</xref> whilst the expression of hepatic DNL‐related genes is also reduced by states of chronic negative energy balance.<xref rid="dom13500-bib-0020" ref-type="ref">20</xref> This may explain the disparate effect of inulin supplementation on liver fat content in the current study compared with our previous investigation when inulin intervention was added to a hypocaloric diet that achieved a ~5% reduction in body weight.<xref rid="dom13500-bib-0013" ref-type="ref">13</xref>
</p>
              <p>IPE supplementation did not significantly raise IHCL content, as observed within the inulin‐control group. The contrasting outcome could be because of differences in the amounts of acetate derived from inulin fermentation throughout the supplementation period, as the inulin‐control group were provided with a greater amount of inulin compared to IPE (20 g/d vs. 14.6 g/d). In vitro faecal fermentation profiles have previously showed, however, that comparable quantities of acetate are produced from equivalent doses of inulin and IPE.<xref rid="dom13500-bib-0009" ref-type="ref">9</xref> Interestingly, IPE does substantially alter the proportion of SCFAs produced, as the molar ratio of acetate, propionate and butyrate changes from 74:16:10 with inulin to 25:69:6 with an equivalent amount of IPE.<xref rid="dom13500-bib-0009" ref-type="ref">9</xref> It could be suggested that the elevated ratio of colonic propionate : acetate promoted by IPE supplementation may have prevented the accumulation of liver fat observed in the inulin‐control group by impairing hepatic acetate metabolism. This proposed mechanism is concordant with the results from Wolever and colleagues, who showed using stable isotope technology that propionate inhibits incorporation of colonic [1,2‐<sup>13</sup>C] acetate into plasma lipids in humans.<xref rid="dom13500-bib-0007" ref-type="ref">7</xref> Studies using rat hepatocytes have also highlighted that propionate inhibits lipid synthesis when acetate is a major source of acetyl‐CoA.<xref rid="dom13500-bib-0008" ref-type="ref">8</xref> Recent evidence has showed a third ACSS isoform, <italic>ACSS3</italic>, for which propionate is the preferred substrate over acetate, and which is highly expressed in the mitochondrial matrix of hepatocytes.<xref rid="dom13500-bib-0016" ref-type="ref">16</xref>
<italic>ACSS3</italic> converts propionate to propionyl‐CoA allowing it to enter mitochondrial respiration through succinate and the TCA cycle.<xref rid="dom13500-bib-0016" ref-type="ref">16</xref> Elevating hepatic propionate metabolism would therefore increase competition with acetate for conversion into their CoA adducts at tissue level, which may reduce cytosolic acetyl‐CoA availability for DNL. This potential mechanism is supported by a recent observation that exposing HepG2 cells to elevated ratios of propionate : acetate increases the formation of heptadecanoic acid derived from propionyl‐CoA, which inhibits the synthesis of palmitate from acetyl‐CoA.<xref rid="dom13500-bib-0021" ref-type="ref">21</xref>
</p>
              <p>The present study has a number of potential limitations, chiefly, the considerable variability in metabolic health of the recruited volunteers. Nevertheless, the individual change in IHCL postsupplementation was not associated with any baseline metabolic variable (Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S6</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>) and significant differences between groups at baseline were only found in two outcome measures (cholesterol and LDL‐cholesterol). In addition, the inclusion criteria permitted a histological diagnosis of NAFLD within the previous 5 years, thus a volunteer's histological characterization could have changed in the timeframe between initial diagnosis and recruitment into the study. However, all volunteers exhibited a raised IHCL (&gt;5%) when assessed at baseline (Table <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>, File <xref rid="dom13500-supitem-0001" ref-type="supplementary-material">S1</xref>).</p>
              <p>In conclusion, inulin consumed at 20 g/d increased IHCL in body weight‐stable adults with NAFLD, an effect not observed with IPE supplementation. We speculate that in the context of NAFLD and a hepatic metabolic profile that stimulates DNL, the acetate derived from colonic fermentation of inulin could provide an additional lipogenic precursor to the liver. The increased colonic delivery of propionate from IPE appears to attenuate this acetate‐mediated increase in IHCL, possibly by interfering with the availability of acetate‐derived acetyl‐CoA for DNL. Further work is warranted to explore how altering colonic SCFA production profiles modulates the metabolic pathways that govern hepatic lipid storage in humans. In particular, future research should determine how the hepatic metabolic processing of acetate and propionate changes in different states of energy balance, and how to make distinctions between NAFLD patients and healthy controls.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="dom13500-supitem-0001">
                <caption>
                  <p><bold>File S1.</bold> A detailed methodology.</p>
                  <p><bold>Figure S1.</bold> Recruitment and retention in the study. Inulin‐propionate ester (IPE).</p>
                  <p><bold>Figure S2.</bold> The effects of 42 days of inulin control and inulin propionate ester (IPE) supplementation on postprandial A, glucose and B, insulin responses. (Data are expressed as mean ± SEM (n = 8 each group).</p>
                  <p><bold>Table S1.</bold> Volunteer characteristics. Histological assessment of the liver from biopsy. Intra hepatocellular lipid (IHCL) content, alanine transaminase, HbA1c, metabolic comorbidities and medications at baseline.</p>
                  <p><bold>Table S2.</bold> Changes in fasting and postprandial metabolic responses following 42 days of inulin‐control or inulin propionate ester (IPE) supplementation. Data are expressed as mean ± SEM or 95% CI.</p>
                  <p><bold>Table S3.</bold> Changes in fasting and postprandial SCFA following 42 days of inulin‐control or inulin propionate ester (IPE) supplementation. Data are expressed as mean ± SEM or 95% CI.</p>
                  <p><bold>Table S4.</bold> Changes in inflammatory markers following 42 days of inulin‐control or inulin propionate ester (IPE) supplementation. Data are expressed as mean ± SEM or 95% CI.</p>
                  <p><bold>Table S5.</bold> Changes in self‐reported food intake, physical activity and gastrointestinal side‐effects following 42 days of inulin‐control or propionate ester (IPE) supplementation. Data are expressed as mean ± SEM or 95% CI.</p>
                  <p><bold>Table S6.</bold> Correlations between baseline variables and the delta change (Δ) in IHCL following 42 days of inulin‐control or propionate ester (IPE) supplementation.</p>
                </caption>
                <media xlink:href="DOM-21-372-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="dom13500-sec-0004">
              <title>ACKNOWLEDGMENTS</title>
              <p>The Section of Investigative Medicine is funded by grants from the MRC and BBSRC, and is supported by the NIHR Imperial Biomedical Research Centre Funding Scheme. This research study was supported by the NIHR Clinical Research Facility at Imperial College Healthcare NHS Trust. The research was supported by an MRC Confidence in Concept fund. E. S. C. was supported by a British Nutrition Foundation Drummond Pump Priming Award. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.</p>
              <sec sec-type="COI-statement" id="dom13500-sec-0005">
                <title>Conflicts of interest</title>
                <p>A patent application for “Compounds and their effects on appetite control and insulin sensitivity” surrounding the use of inulin‐propionate ester has been filed by G. F. and D. J. M. (WO2014020344). None of the other authors report a conflict of interest related to this study.</p>
              </sec>
              <sec id="dom13500-sec-0006">
                <title>Author contributions</title>
                <p>The study was designed by GF, MRT, RS, ESC, DJM and TP. Data were collected and analysed by ESC, CSB, AR, CT, JDB, LT, ANA, NER and PM. The article was drafted by ESC, DJM and GF. All authors revised the article and gave their final approval of the current version to be published.</p>
              </sec>
            </ack>
            <ref-list id="dom13500-bibl-0001" content-type="cited-references">
              <title>REFERENCES</title>
              <ref id="dom13500-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0001"><string-name><surname>Lazo</surname><given-names>M</given-names></string-name>, <string-name><surname>Clark</surname><given-names>JM</given-names></string-name>. <article-title>The epidemiology of nonalcoholic fatty liver disease: a global perspective</article-title>. <source xml:lang="en">Semin Liver Dis</source>. <year>2008</year>;<volume>28</volume>(<issue>4</issue>):<fpage>339</fpage>‐<lpage>350</lpage>.<pub-id pub-id-type="pmid">18956290</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0002"><string-name><surname>Lowe</surname><given-names>MR</given-names></string-name>, <string-name><surname>Miller‐Kovach</surname><given-names>K</given-names></string-name>, <string-name><surname>Phelan</surname><given-names>S</given-names></string-name>. <article-title>Weight‐loss maintenance in overweight individuals one to five years following successful completion of a commercial weight loss program</article-title>. <source xml:lang="en">Int J Obes Relat Metab Disord</source>. <year>2001</year>;<volume>25</volume>(<issue>3</issue>):<fpage>325</fpage>‐<lpage>331</lpage>.<pub-id pub-id-type="pmid">11319628</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0003"><string-name><surname>Anastasovska</surname><given-names>J</given-names></string-name>, <string-name><surname>Arora</surname><given-names>T</given-names></string-name>, <string-name><surname>Sanchez Canon</surname><given-names>GJ</given-names></string-name>, et al. <article-title>Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment</article-title>. <source xml:lang="en">Obesity</source>. <year>2012</year>;<volume>20</volume>(<issue>5</issue>):<fpage>1016</fpage>‐<lpage>1023</lpage>.<pub-id pub-id-type="pmid">22322344</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0004"><string-name><surname>Kumar</surname><given-names>SA</given-names></string-name>, <string-name><surname>Ward</surname><given-names>LC</given-names></string-name>, <string-name><surname>Brown</surname><given-names>L</given-names></string-name>. <article-title>Inulin oligofructose attenuates metabolic syndrome in high‐carbohydrate, high‐fat diet‐fed rats</article-title>. <source xml:lang="en">Br J Nutr</source>. <year>2016</year>;<volume>116</volume>(<issue>9</issue>):<fpage>1502</fpage>‐<lpage>1511</lpage>.<pub-id pub-id-type="pmid">27805541</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0005"><string-name><surname>Weitkunat</surname><given-names>K</given-names></string-name>, <string-name><surname>Stuhlmann</surname><given-names>C</given-names></string-name>, <string-name><surname>Postel</surname><given-names>A</given-names></string-name>, et al. <article-title>Short‐chain fatty acids and inulin, but not guar gum, prevent diet‐induced obesity and insulin resistance through differential mechanisms in mice</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>6109</fpage>.<pub-id pub-id-type="pmid">28733671</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0006"><string-name><surname>Peters</surname><given-names>SG</given-names></string-name>, <string-name><surname>Pomare</surname><given-names>EW</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>CA</given-names></string-name>. <article-title>Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery</article-title>. <source xml:lang="en">Gut</source>. <year>1992</year>;<volume>33</volume>(<issue>9</issue>):<fpage>1249</fpage>‐<lpage>1252</lpage>.<pub-id pub-id-type="pmid">1427380</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0007"><string-name><surname>Wolever</surname><given-names>TM</given-names></string-name>, <string-name><surname>Spadafora</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Cunnane</surname><given-names>SC</given-names></string-name>, <string-name><surname>Pencharz</surname><given-names>PB</given-names></string-name>. <article-title>Propionate inhibits incorporation of colonic [1,2‐13C]acetate into plasma lipids in humans</article-title>. <source xml:lang="en">Am J Clin Nutr</source>. <year>1995</year>;<volume>61</volume>(<issue>6</issue>):<fpage>1241</fpage>‐<lpage>1247</lpage>.<pub-id pub-id-type="pmid">7762524</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0008"><string-name><surname>Demigne</surname><given-names>C</given-names></string-name>, <string-name><surname>Morand</surname><given-names>C</given-names></string-name>, <string-name><surname>Levrat</surname><given-names>MA</given-names></string-name>, <string-name><surname>Besson</surname><given-names>C</given-names></string-name>, <string-name><surname>Moundras</surname><given-names>C</given-names></string-name>, <string-name><surname>Remesy</surname><given-names>C</given-names></string-name>. <article-title>Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes</article-title>. <source xml:lang="en">Br J Nutr</source>. <year>1995</year>;<volume>74</volume>(<issue>2</issue>):<fpage>209</fpage>‐<lpage>219</lpage>.<pub-id pub-id-type="pmid">7547838</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0009"><string-name><surname>Chambers</surname><given-names>ES</given-names></string-name>, <string-name><surname>Viardot</surname><given-names>A</given-names></string-name>, <string-name><surname>Psichas</surname><given-names>A</given-names></string-name>, et al. <article-title>Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults</article-title>. <source xml:lang="en">Gut</source>. <year>2015</year>;<volume>64</volume>(<issue>11</issue>):<fpage>1744</fpage>‐<lpage>1754</lpage>.<pub-id pub-id-type="pmid">25500202</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0010"><string-name><surname>Boets</surname><given-names>E</given-names></string-name>, <string-name><surname>Deroover</surname><given-names>L</given-names></string-name>, <string-name><surname>Houben</surname><given-names>E</given-names></string-name>, et al. <article-title>Quantification of in vivo colonic short chain fatty acid production from inulin</article-title>. <source xml:lang="en">Nutrients</source>. <year>2015</year>;<volume>7</volume>(<issue>11</issue>):<fpage>8916</fpage>‐<lpage>8929</lpage>.<pub-id pub-id-type="pmid">26516911</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0011"><string-name><surname>Liu</surname><given-names>F</given-names></string-name>, <string-name><surname>Prabhakar</surname><given-names>M</given-names></string-name>, <string-name><surname>Ju</surname><given-names>J</given-names></string-name>, <string-name><surname>Long</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>HW</given-names></string-name>. <article-title>Effect of inulin‐type fructans on blood lipid profile and glucose level: a systematic review and meta‐analysis of randomized controlled trials</article-title>. <source xml:lang="en">Eur J Clin Nutr</source>. <year>2017</year>;<volume>71</volume>(<issue>1</issue>):<fpage>9</fpage>‐<lpage>20</lpage>.<pub-id pub-id-type="pmid">27623982</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0012"><string-name><surname>Daud</surname><given-names>NM</given-names></string-name>, <string-name><surname>Ismail</surname><given-names>NA</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>EL</given-names></string-name>, et al. <article-title>The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity</article-title>. <source xml:lang="en">Obesity</source>. <year>2014</year>;<volume>22</volume>(<issue>6</issue>):<fpage>1430</fpage>‐<lpage>1438</lpage>.<pub-id pub-id-type="pmid">24715424</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0013"><string-name><surname>Guess</surname><given-names>ND</given-names></string-name>, <string-name><surname>Dornhorst</surname><given-names>A</given-names></string-name>, <string-name><surname>Oliver</surname><given-names>N</given-names></string-name>, <string-name><surname>Bell</surname><given-names>JD</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>EL</given-names></string-name>, <string-name><surname>Frost</surname><given-names>GS</given-names></string-name>. <article-title>A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes</article-title>. <source xml:lang="en">Nutr Metab (Lond)</source>. <year>2015</year>;<volume>12</volume>:<fpage>36</fpage>.<pub-id pub-id-type="pmid">26500686</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0014"><string-name><surname>Marques‐Lopes</surname><given-names>I</given-names></string-name>, <string-name><surname>Ansorena</surname><given-names>D</given-names></string-name>, <string-name><surname>Astiasaran</surname><given-names>I</given-names></string-name>, <string-name><surname>Forga</surname><given-names>L</given-names></string-name>, <string-name><surname>Martinez</surname><given-names>JA</given-names></string-name>. <article-title>Postprandial de novo lipogenesis and metabolic changes induced by a high‐carbohydrate, low‐fat meal in lean and overweight men</article-title>. <source xml:lang="en">Am J Clin Nutr</source>. <year>2001</year>;<volume>73</volume>(<issue>2</issue>):<fpage>253</fpage>‐<lpage>261</lpage>.<pub-id pub-id-type="pmid">11157321</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0015"><string-name><surname>Perry</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Peng</surname><given-names>L</given-names></string-name>, <string-name><surname>Barry</surname><given-names>NA</given-names></string-name>, et al. <article-title>Acetate mediates a microbiome‐brain‐beta‐cell axis to promote metabolic syndrome</article-title>. <source xml:lang="en">Nature</source>. <year>2016</year>;<volume>534</volume>(<issue>7606</issue>):<fpage>213</fpage>‐<lpage>217</lpage>.<pub-id pub-id-type="pmid">27279214</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0016"><string-name><surname>Yoshimura</surname><given-names>Y</given-names></string-name>, <string-name><surname>Araki</surname><given-names>A</given-names></string-name>, <string-name><surname>Maruta</surname><given-names>H</given-names></string-name>, <string-name><surname>Takahashi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>H</given-names></string-name>. <article-title>Molecular cloning of rat acss3 and characterization of mammalian propionyl‐CoA synthetase in the liver mitochondrial matrix</article-title>. <source xml:lang="en">J Biochem</source>. <year>2017</year>;<volume>161</volume>(<issue>3</issue>):<fpage>279</fpage>‐<lpage>289</lpage>.<pub-id pub-id-type="pmid">28003429</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0017"><string-name><surname>Lambert</surname><given-names>JE</given-names></string-name>, <string-name><surname>Ramos‐Roman</surname><given-names>MA</given-names></string-name>, <string-name><surname>Browning</surname><given-names>JD</given-names></string-name>, <string-name><surname>Parks</surname><given-names>EJ</given-names></string-name>. <article-title>Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease</article-title>. <source xml:lang="en">Gastroenterology</source>. <year>2014</year>;<volume>146</volume>(<issue>3</issue>):<fpage>726</fpage>‐<lpage>735</lpage>.<pub-id pub-id-type="pmid">24316260</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0018"><string-name><surname>Mitsuyoshi</surname><given-names>H</given-names></string-name>, <string-name><surname>Yasui</surname><given-names>K</given-names></string-name>, <string-name><surname>Harano</surname><given-names>Y</given-names></string-name>, et al. <article-title>Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease</article-title>. <source xml:lang="en">Hepatol Res</source>. <year>2009</year>;<volume>39</volume>(<issue>4</issue>):<fpage>366</fpage>‐<lpage>373</lpage>.<pub-id pub-id-type="pmid">19054139</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0019"><string-name><surname>Kowalski</surname><given-names>GM</given-names></string-name>, <string-name><surname>Hamley</surname><given-names>S</given-names></string-name>, <string-name><surname>Selathurai</surname><given-names>A</given-names></string-name>, et al. <article-title>Reversing diet‐induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2016</year>;<volume>6</volume>:27541.</mixed-citation>
              </ref>
              <ref id="dom13500-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0020"><string-name><surname>Uebanso</surname><given-names>T</given-names></string-name>, <string-name><surname>Taketani</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fukaya</surname><given-names>M</given-names></string-name>, et al. <article-title>Hypocaloric high‐protein diet improves fatty liver and hypertriglyceridemia in sucrose‐fed obese rats via two pathways</article-title>. <source xml:lang="en">Am J Physiol Endocrinol Metab</source>. <year>2009</year>;<volume>297</volume>(<issue>1</issue>):<fpage>E76</fpage>‐<lpage>E84</lpage>.<pub-id pub-id-type="pmid">19435858</pub-id></mixed-citation>
              </ref>
              <ref id="dom13500-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="dom13500-cit-0021"><string-name><surname>Weitkunat</surname><given-names>K</given-names></string-name>, <string-name><surname>Schumann</surname><given-names>S</given-names></string-name>, <string-name><surname>Nickel</surname><given-names>D</given-names></string-name>, et al. <article-title>Odd‐chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate</article-title>. <source xml:lang="en">Am J Clin Nutr</source>. <year>2017</year>;<volume>105</volume>(<issue>6</issue>):<fpage>1544</fpage>‐<lpage>1551</lpage>.<pub-id pub-id-type="pmid">28424190</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
